個性化醫療市場規模、份額和趨勢分析報告:按產品(個性化營養/健康、個性化藥物治療)、地區、細分市場預測,2022-2030 年
市場調查報告書
商品編碼
1170859

個性化醫療市場規模、份額和趨勢分析報告:按產品(個性化營養/健康、個性化藥物治療)、地區、細分市場預測,2022-2030 年

Personalized Medicine Market Size, Share & Trends Analysis Report By Product (Personalized Nutrition & Wellness, Personalized Medicine Therapeutics), By Region, And Segment Forecasts, 2022 - 2030

出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

個性化醫療市場的增長和趨勢

根據 Grand View Research, Inc. 的最新報告,到 2030 年,全球個性化醫療市場預計將達到 9227.2 億美元。 由於疾病發病率的增加和對新療法的需求不斷增長,該市場預計從 2022 年到 2030 年的複合年增長率為 6.95%。 大量的研究工作不斷加強個性化醫療的新興應用。 例如,2022 年 7 月,UMass Chan 醫學院的研究人員將開發基於微生物學的個體化微生物,以幫助理解代謝波動,測量它們與個體基因組、飲食、微生物組和相關環境因素的關聯,並開發出醫學模型系統。

許多癌症病症通常是由潛在的基因錯配引起的,發展到晚期可能會致命。 通過了解特定的基因組特徵,可以有效、準確地治療癌症病症。 例如,2020 年 5 月,Qiagen 發布了 QIAseq pancancer multimodal,能夠對癌症受試者的基因組特徵進行穩健分析,從而在精準醫學中廣泛應用於實體瘤和血紅素惡性腫瘤的分析。

NGS 技術的進步和對人類基因組的廣泛研究正在積極推動這個市場。 人們越來越關注利用 NGS 來推動潛在的個性化醫療結果,以治療癌症和罕見遺傳病。 例如,Illumina 已宣布將在巴黎舉行的歐洲腫瘤學會 (ESMO) 年會上介紹幾項腫瘤學研究的執行摘要。 Illumina 研究使用活組織檢查的全面基因組分析來將受試者與潛在藥物和免疫療法相匹配,從而實現個性化的癌症治療。

遠程醫療以虛擬方式或通過電話提供臨床建議,以提供更大的身體便利。 遠程醫療變得越來越流行,尤其是自 COVID-19 大流行以來。 政府和研究機構正在努力加強個性化遠程醫療的應用。 例如,2022 年 8 月,國家癌症研究所承諾在五年內提供 2300 萬美元的贈款,以幫助在全國啟動遠程醫療研究中心 (TRACE)。 該計劃由白宮癌症登月計劃支持,其使命是利用健康差異來開發和推進癌症護理的遠程醫療服務。

分子成像設備和醫療設備在個性化醫療的新進展中發揮著重要作用。 這些設備可以有效地利用個性化醫療來治療各種類型的癌症。 例如,2022 年 6 月,GE Healthcare 宣布將推出前列腺癌診斷和監測,以利用精準醫療和治療診斷學在癌症進展的早期階段進行個性化前列腺癌治療。鎵68放射性同位素

隨著新技術的進步以及聯合研究和擴張等持續的行業努力,市場正處於增長階段。 例如,2021 年 12 月,Biogen 和 Therapanacia 宣布了一項合作,重點是推進神經科學個性化醫療的數字健康。

個性化醫療市場報告亮點

市場的整體增長歸因於對利用遺傳水平對疾病的理解的新型治療藥物的不斷增長的需求以及全球癌症和遺傳疾病發病率的上升。

由於藥物遺傳學在生物製藥開發中的廣泛應用,個性化治療領域有望在預測期內實現高速增長。 此外,由於全基因組測序成本的顯著降低,預計基因組治療領域在預測期內將顯著增長。

北美在 2021 年佔據了市場主導地位,原因是主要參與者的存在以及對新療法開發的深入研究,以尋找治療各種疾病的方法。

內容

第一章調查方法及範圍

  • 調查範圍
  • 調查方法
  • 信息採購
    • 購買的數據庫
    • GVR 內部數據庫
    • 次要信息
    • 初步調查
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 目的

第 2 章執行摘要

  • 個性化醫療市場:市場展望

第 3 章市場變量、趨勢和範圍

  • 市場趨勢和前景
  • 趨勢分析
    • 產品趨勢
      • 個性化醫療診斷的趨勢
      • 個性化醫療的治療趨勢
      • 個性化醫療的趨勢
      • 個性化營養和健康的趨勢
  • 市場細分和範圍
  • 市場動態
    • 市場驅動因素分析
      • 人類基因組數據在臨床研究中的實用性
      • 有針對性的個性化醫療保健
      • 推動個性化醫療研發的技術進步
      • 先進基因組編輯技術的出現
      • 新數據庫對研究的實用性
    • 市場製約因素分析
      • 個人基因組數據的倫理問題和保護
      • 有限訪問人類基因組數據和數據庫
    • 機會分析
  • COVID-19 大流行對個性化醫療市場的影響
  • 2021 年產品滲透率和增長前景圖
  • 商業環境分析
    • 個性化醫療市場 - SWOT 分析,按因素(政治與法律、經濟與技術)
    • 波特的五力分析
  • 市場份額分析
    • 公司規模
    • 產品組合
    • 戰略舉措
  • 競爭格局
    • 戰略框架
    • 市場參與分類
      • 新/新進入者
      • 成熟的參與者和領導者

第四章產品業務分析

  • 個性化醫療診斷
    • 基因檢測
    • 直接面向消費者 (DTC) 的測試
    • 奧術實驗室服務
    • 奧術實驗室測試
  • 個性化醫療
    • 醫藥
    • 基因組醫學
    • 醫療設備
  • 個性化醫療
    • 遠程醫療
    • 健康信息技術
  • 個性化營養和健康
    • 零售營養
    • 補充和替代醫學

第 5 章按區域劃分的業務分析

    • 個性化醫療市場:2021 年和 2030 年各地區趨勢分析
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 韓國
  • 拉丁美洲 (LATAM)
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲 (MEA)
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國

第六章公司簡介

  • 公司簡介
    • GE Healthcare
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Illumina, Inc.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • ASURAGEN, INC.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Abbott
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Dako A/S
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Exact Sciences Corporation
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Cepheid, Inc.(Danaher Corporation)
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Decode Genetics, Inc.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • QIAGEN, Inc.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Exagen Inc.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Precision Biologics
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Celera Diagnostics LLC
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Biogen
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Genelex(Invitae Corporation)
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • International Business Machines Corporation(IBM)
      • 公司簡介
      • 產品基準
      • 戰略舉措
    • Genentech, Inc.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 23 andMe, Inc.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
Product Code: 978-1-68038-443-7

Personalized Medicine Market Growth & Trends:

The global personalized medicine market size is expected to reach USD 922.72 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 6.95% from 2022 to 2030 owing to the increasing incidence of diseases and the rising demand for novel therapeutic drugs. The emerging applications of personalized medicine are consistently enhanced by immense research efforts. For instance, in July 2022, researchers at the UMass Chan Medical School developed a microorganism-based personalized medicine model system to aid the understanding of variation in metabolism to gauge the connection between an individual's genome, diet, microbiota, and associative environmental factors.

Most cancer conditions are usually caused by an underlying genetic discrepancy and can cause fatalities with progression. The cancer condition can be effectively and precisely treated by understanding specific genomic characteristics. For instance, in May 2020, Qiagen launched QIAseq pan-cancer multi-modal panel to enable robust analysis of genomic characteristics of cancer subjects to derive a broad spectrum of applications in precision medicine for the profiling of solid tumors and heme malignancies.

The market is positively driven by advancements in NGS technologies and extensive research on the human genome. There has been an increasing focus on utilizing NGS to derive personalized medicine outcomes that could potentially be used for the treatment of cancer and rare genetic disorders. For instance, Illumina declared that it will present its multiple oncology research abstracts at the European Society of Medical Oncology (ESMO) annual meeting in Paris. Their research enables personalized cancer care using comprehensive genomic profiling of biopsies to match subjects to the potential drugs and immunotherapies.

Telemedicine facilitates virtual or telephonic clinical advice to aid physical convenience. Telemedicine is increasingly trending, especially after the COVID-19 pandemic. Government and research institutes are taking substantial efforts to enhance the applications of personalized telemedicine. For instance, in August 2022, the National Cancer Institute declared a grant of USD 23 million for five years to aid the launch of Telehealth Research Centers of Excellence (TRACE) across the U.S. The program was launched with the support of the White House Cancer Moonshot to seek development and advancements in telehealth delivery for cancer care with a mission to leverage health equity.

Molecular imaging systems and medical devices are playing a primary role in emerging advancements in personalized medicine. They effectively leverage the applications of personalized medicine in the treatment of different types of cancers. For instance, in June 2022, GE Healthcare declared the release of high-end molecular imaging by using gallium-68 radioisotope for the diagnosis and monitoring of prostate cancer so as to leverage access to precision health and theranostics for personalized prostate cancer treatment at an early stage of cancer progression.

The market is in the growth phase due to emerging technological advancements along with consistent industrial efforts such as collaborations and expansions. For instance, in December 2021, Biogen Inc., and TheraPanacea declared that they have signed a collaboration that focuses on advancing digital health for personalized medicine in neuroscience.

Personalized Medicine Market Report Highlights:

  • The overall growth of the market is attributed to the rising need for novel therapeutic drugs coupled with leveraged genetic level understanding of diseases and the rising incidence of cancers and genetic disorders across the globe
  • The personalized medicine therapeutics segment is anticipated to witness high growth over the forecast period owing to the extensive usage of pharmacogenomics for developing biopharmaceuticals. Further, the genomic medicine therapeutics segment is anticipated to grow substantially during the forecast period owing to significantly lowered costs of whole-genome sequencing
  • North America dominated the market in 2021 due to the presence of key players and their intensive research for the development of novel therapies to find out curative solutions for various diseases

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Research Scope
    • 1.1.1 Estimates and Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Objectives
    • 1.6.1 Objective 1
    • 1.6.2 Objective 2

Chapter 2 Executive Summary

  • 2.1 Personalized Medicine Market: Market Outlook

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Trends & Outlook
  • 3.2 Trend Analysis
    • 3.2.1 Product Trends
      • 3.2.1.1 Personalized Medicine Diagnostics Trends
      • 3.2.1.2 Personalized Medicine Therapeutics Trends
      • 3.2.1.3 Personalized Medical Care Trends
      • 3.2.1.4 Personalized Nutrition & Wellness Trends
  • 3.3 Market Segmentation & Scope
  • 3.4 Market Dynamics
    • 3.4.1 Market driver analysis
      • 3.4.1.1 Utility of human genome data for clinical research
      • 3.4.1.1.1Targeted and personalized healthcare
      • 3.4.1.2 Technological advancements to facilitate R&D for Personalized Medicine
      • 3.4.1.2.1 Emergence of advanced genome editing techniques
      • 3.4.1.2.2 Utility of novel databases for research
    • 3.4.2 Market restraint analysis
      • 3.4.2.1 Ethical issues and protection of individual's genomic data
      • 3.4.2.2 Limited access to human genome data and databases
    • 3.4.3 Opportunity analysis
  • 3.5 Impact of COVID - 19 Pandemic on Personalized Medicine Market
  • 3.6 Penetration & Growth Prospect Mapping for Products, 2021
  • 3.7 Business Environment Analysis
    • 3.7.1 Personalized Medicine Market - Swot Analysis, By Factor (Political & Legal, Economic And Technological)
    • 3.7.2 Porter's Five Forces Analysis
  • 3.8 Market Share Analysis
    • 3.8.1 Company Size
    • 3.8.2 Product portfolio
    • 3.8.3 Strategic Initiatives
  • 3.9 Competitive Landscape
    • 3.9.1 Strategy Framework
    • 3.9.2 Market Participation Categorization
      • 3.9.2.1 New/ emerging entrants
      • 3.9.2.2 Mature players & leaders

Chapter 4 Product Business Analysis

  • 4.1 Personalized Medicine Diagnostics
    • 4.1.1 Global Personalized Medicine Diagnostics Market, 2018 - 2030 (USD Billion)
    • 4.1.2 Genetic Testing
      • 4.1.2.1 Global Personalized Medicine Market for Genetic Testing, 2018 - 2030 (USD Billion)
    • 4.1.3 Direct - To - Consumer (DTC) Testing
      • 4.1.3.1 Global Personalized Medicine Market for Direct - To - Consumer (DTC) Testing, 2018 - 2030 (USD Billion)
    • 4.1.4 Esoteric Lab Services
      • 4.1.4.1 Global Personalized Medicine Market for Esoteric Lab Services, 2018 - 2030 (USD Billion)
    • 4.1.5 Esoteric Lab Tests
      • 4.1.5.1 Global Personalized Medicine Market for Esoteric Lab Services, 2018 - 2030 (USD Billion)
  • 4.2 Personalized Medicine Therapeutics
    • 4.2.1 Global Personalized Medicine TherapeuticsMarket, 2018 - 2030 (USD Billion)
    • 4.2.2 Pharmaceuticals
      • 4.1.2.1 Global Personalized Therapeutics Market for Pharmaceuticals, 2018 - 2030 (USD Billion)
    • 4.1.3 Genomic Medicine
      • 4.1.3.1 Global Personalized Therapeutics Market for Genomic Medicine, 2018 - 2030 (USD Billion)
    • 4.1.4 Medical Devices
      • 4.1.4.1 Global Personalized TherapeuticsMarket for Medical Devices, 2018 - 2030 (USD Billion)
  • 4.3 Personalized Medical Care
    • 4.2.1 Global Personalized Medical CareMarket, 2018 - 2030 (USD Billion)
    • 4.2.2 Telemedicine
      • 4.1.2.1 Global Personalized Medical Care Market for Telemedicine, 2018 - 2030 (USD Billion)
    • 4.1.3 Health Information Technology
      • 4.1.3.1 Global Personalized Medical Care Market for Health Information Technology, 2018 - 2030 (USD Billion)
  • 4.3 Personalized Nutrition & Wellness
    • 4.2.1 Global Personalized Nutrition & WellnessMarket, 2018 - 2030 (USD Billion)
    • 4.2.2 Retail Nutrition
      • 4.1.2.1 Global Nutrition & Wellness Market for Retail Nutrition, 2018 - 2030 (USD Billion)
    • 4.1.3 Complementary & Alternative Medicine
      • 4.1.3.1 Global Nutrition & Wellness Market for Complementary & Alternative Medicine, 2018 - 2030 (USD Billion)

Chapter 5 Regional Business Analysis

      • 5.1Persoanlized Medicine Market: Regional Movement Analysis, 2021 & 2030
  • 5.2 North America
    • 5.2.1 North America market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.2.2 U.S.
      • 5.2.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.2.3 Canada
      • 5.2.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Billion)
  • 5.3 Europe
    • 5.3.1 Europe market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.3.2 Germany
      • 5.3.2.1 Germany market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.3.3 U.K.
      • 5.3.3.1 U.K. market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.3.4 France
      • 5.3.4.1 France market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.3.5 Italy
      • 5.3.5.1 Italy market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.3.6 Spain
      • 5.3.6.1 Spain market estimates and forecast, 2018 - 2030 (USD Billion)
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.4.2 Japan
      • 5.4.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.4.3 China
      • 5.4.3.1 China market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.4.4 India
      • 5.4.4.1 India market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.4.5 Australia
      • 5.4.5.1 Australia market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.4.6 South Korea
      • 5.4.6.1 South Korea market estimates and forecast, 2018 - 2030 (USD Billion)
  • 5.5 Latin America (LATAM)
    • 5.5.1 Latin America market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.5.2 Brazil
      • 5.5.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.5.3 Mexico
      • 5.5.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.5.4 Argentina
      • 5.5.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Billion)
  • 5.6 Middle East and Africa (MEA)
    • 5.6.1 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.6.2 South Africa
      • 5.6.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.6.3 Saudi Arabia
      • 5.6.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.6.4 UAE
      • 5.6.4.1 UAE market estimates and forecast, 2018 - 2030 (USD Billion)

Chapter 6 Company Profiles

  • 6.1 Company Profiles
    • 6.1.1 GE Healthcare
      • 6.1.1.1 Company Overview
      • 6.1.1.2 Financial Performance
      • 6.1.1.3 Product Benchmarking
      • 6.1.1.4 Strategic Initiatives
    • 6.1.2 Illumina, Inc.
      • 6.1.2.1 Company Overview
      • 6.1.2.2 Financial Performance
      • 6.1.2.3 Product Benchmarking
      • 6.1.2.4 Strategic Initiatives
    • 6.1.3 ASURAGEN, INC.
      • 6.1.3.1 Company Overview
      • 6.1.3.2 Financial Performance
      • 6.1.3.3 Product Benchmarking
      • 6.1.3.4 Strategic Initiatives
    • 6.1.4 Abbott
      • 6.1.4.1 Company Overview
      • 6.1.4.2 Financial Performance
      • 6.1.4.3 Product Benchmarking
      • 6.1.4.4 Strategic Initiatives
    • 6.1.5 Dako A/S
      • 6.1.5.1 Company Overview
      • 6.1.5.2 Financial Performance
      • 6.1.5.3 Product Benchmarking
      • 6.1.5.4 Strategic Initiatives
    • 6.1.6 Exact Sciences Corporation
      • 6.1.6.1 Company Overview
      • 6.1.6.1 Financial Performance
      • 6.1.6.2 Product Benchmarking
      • 6.1.6.3 Strategic Initiatives
    • 6.1.7 Cepheid, Inc. (Danaher Corporation)
      • 6.1.7.1 Company Overview
      • 6.1.7.2 Financial Performance
      • 6.1.7.3 Product Benchmarking
      • 6.1.7.4 Strategic Initiatives
    • 6.1.8 Decode Genetics, Inc.
      • 6.1.8.1 Company Overview
      • 6.1.8.2 Financial Performance
      • 6.1.8.3 Product Benchmarking
      • 6.1.8.4 Strategic Initiatives
    • 6.1.9 QIAGEN, Inc.
      • 6.1.9.1 Company Overview
      • 6.1.9.2 Financial Performance
      • 6.1.9.3 Product Benchmarking
      • 6.1.9.4 Strategic Initiatives
    • 6.1.10 Exagen Inc.
      • 6.1.10.1 Company Overview
      • 6.1.10.2 Financial Performance
      • 6.1.10.3 Product Benchmarking
      • 6.1.10.4 Strategic Initiatives
    • 6.1.11 Precision Biologics
      • 6.1.11.1 Company Overview
      • 6.1.11.2 Financial Performance
      • 6.1.11.3 Product Benchmarking
      • 6.1.11.4 Strategic Initiatives
    • 6.1.12 Celera Diagnostics LLC
      • 6.1.12.1 Company Overview
      • 6.1.12.2 Financial Performance
      • 6.1.12.3 Product Benchmarking
      • 6.1.12.4 Strategic Initiatives
    • 6.1.13 Biogen
      • 6.1.13.1 Company Overview
      • 6.1.13.2 Financial Performance
      • 6.1.13.3 Product Benchmarking
      • 6.1.13.4 Strategic Initiatives
    • 6.1.14 Genelex (Invitae Corporation)
      • 6.1.14.1 Company Overview
      • 6.1.14.2 Financial Performance
      • 6.1.14.3 Product Benchmarking
      • 6.1.14.4 Strategic Initiatives
    • 6.1.15 International Business Machines Corporation (IBM)
      • 6.1.15.1 Company Overview
      • 6.1.15.2 Product Benchmarking
      • 6.1.15.3 Strategic Initiatives
    • 6.1.16 Genentech, Inc.
      • 6.1.16.1 Company Overview
      • 6.1.16.2 Financial Performance
      • 6.1.16.3 Product Benchmarking
      • 6.1.16.4 Strategic Initiatives
    • 6.1.17 23 andMe, Inc.
      • 6.1.17.1 Company Overview
      • 6.1.17.2 Financial Performance
      • 6.1.17.3 Product Benchmarking
      • 6.1.17.4 Strategic Initiatives

List of Tables

  • TABLE 1 List of Secondary Sources
  • TABLE 2 List of Abbreviations
  • TABLE 3 Incidence of Diseases
  • TABLE 4 Global Personalized Medicine Market, By Region, 2018 - 2030 (USD Billion)
  • TABLE 5 Global Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 6 North America Personalized Medicine Market, By Country, 2018 - 2030 (USD Billion)
  • TABLE 7 North America Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 8 U.S. Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 9 Canada Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 10 Europe Personalized Medicine Market, By Country, 2018 - 2030 (USD Billion)
  • TABLE 11 Europe Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 12 Germany Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 13 U.K. Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 14 France Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 15 Italy Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 16 Spain Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 17 Asia Pacific Personalized Medicine Market, By Country, 2018 - 2030 (USD Billion)
  • TABLE 18 Asia Pacific Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 19 Japan Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 20 China Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 21 India Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 22 South Korea Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 23 Australia Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 24 Latin America Personalized Medicine Market, By Country, 2018 - 2030 (USD Billion)
  • TABLE 25 Latin America Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 26 Brazil Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 27 Mexico Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 28 Argentina Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 29 Middle East & Africa Personalized Medicine Market, By Country, 2018 - 2030 (USD Billion)
  • TABLE 30 Middle East & Africa Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 31 Saudi Arabia Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 32 South Africa Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 33 UAE Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)

List of Figures

  • FIG. 1 Information Procurement
  • FIG. 2 Primary Research Pattern
  • FIG. 3 Market Research Approaches
  • FIG. 4 Value Chain - Based Sizing & Forecasting
  • FIG. 5 Market Formulation & Validation
  • FIG. 6 Personalized Medicine Market Segmentation
  • FIG. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • FIG. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • FIG. 9 Market Challenge Relevance Analysis (Current & Future Impact)
  • FIG. 10 Penetration & Growth Prospect Mapping
  • FIG. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • FIG. 12 Porter's Five Forces Analysis
  • FIG. 13 Market Penetration Vs Growth Prospect Mapping, 2021
  • FIG. 14 Personalized Medicine Market: Product Key Takeaways
  • FIG. 15 Global Personalized Medicine Market, for Product, 2018 - 2030 (USD Billion)
  • FIG. 16 Global Personalized Medicine Market, for Diagnostics, 2018 - 2030 (USD Billion)
  • FIG. 17 Global Personalized Medicine Market, for Genetic Testing, 2018 - 2030 (USD Billion)
  • FIG. 18 Global Personalized Medicine Market, for Direct - To - Consumer (DTC) Testing, 2018 - 2030 (USD Billion)
  • FIG. 19 Global Personalized Medicine Market, for Esoteric Lab Services, 2018 - 2030 (USD Billion)
  • FIG. 20 Global Personalized Medicine Market, for Esoteric Lab Tests, 2018 - 2030 (USD Billion)
  • FIG. 21 Global Personalized Medicine Market, for Therapeutics, 2018 - 2030 (USD Billion)
  • FIG. 22 Global Personalized Medicine Market, for Pharmaceutical, 2018 - 2030 (USD Billion)
  • FIG. 23 Global Personalized Medicine Market, for Genomic Medicine, 2018 - 2030 (USD Billion)
  • FIG. 24 Global Personalized Medicine Market, for Medical Devices, 2018 - 2030 (USD Billion)
  • FIG. 25 Global Personalized Medicine Market, for Personalized Medical Care, 2018 - 2030 (USD Billion)
  • FIG. 26 Global Personalized Medicine Market, for Telemedicine, 2018 - 2030 (USD Billion)
  • FIG. 27 Global Personalized Medicine Market, for Health Information Technology, 2018 - 2030 (USD Billion)
  • FIG. 28 Global Personalized Medicine Market, for Personalized Nutrition & Wellness, 2018 - 2030 (USD Billion)
  • FIG. 29 Global Personalized Medicine Market, for Retail Nutrition, 2018 - 2030 (USD Billion)
  • FIG. 30 Global Personalized Medicine Market, for Complementary & Alternative Medicine, 2018 - 2030 (USD Billion)
  • FIG. 31 Regional Outlook, 2021 & 2030
  • FIG. 32 North America Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 33 U.S.Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 34 Canada Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 35 Europe Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 36 Germany Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 37 U.K. Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 38 France Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 39 Italy Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 40 Spain Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 41 Asia Pacific Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 42 Japan Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 43 China Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 44 India Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 45 Australia Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 46 South Korea Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 47 Latin America Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 48 Brazil Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 49 Mexico Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 50 Argentina Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 51 Middle East and Africa Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 52 South Africa Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 53 Saudi Arabia Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 54 UAE Personalized Medicine Market, 2018 - 2030 (USD Billion)